Recent Research


Immune cells could be doing much more than we think in protecting our eyes – Jefferson researchers uncover new details. 

Vibrant hand painted and vectorized watercolor illustration isolated on white combined with vector elements depicting immunotherapy concept.

New Research shows that women treated for melanoma have twice the mortality rate of men when given two immunotherapies at one time. 

woman lying down

In a first-ever study, a unique spiritual practice called orgasmic meditation, has been found to produce a distinctive pattern of brain function.


Learning how a flexible, inexpensive and non-invasive tool can be used to diagnose and stage common diseases from cancer to heart attack.

white woman sitting on bench

Examining addiction’s impact on family members and the importance of cultural humility.

Stephen K. Klasko, MD, MBA

Eight years after being named President of Thomas Jefferson University and CEO of Jefferson Health, Stephen K. Klasko, MD, MBA, will retire from his position, effective December 31, 2021.

woman in yellow shirt standing outside.

Advocating for vulnerable populations to improve the care experience and health outcomes. 

T-cells attacking cancer cell  illustration of  microscopic photosT-cells attacking cancer cell  illustration of  microscopic photos

CAR-T cells are less sensitive than other types of immunotherapy in detecting and killing melanoma cells, a finding that could help improve immunotherapy sensitivity. 

Remote medical visit between a patient and spouse and their female doctor from the patients point of view while they sit at their kitchen table.

Plans national Consensus Conference on Research in Telehealth

woman standing with exercise ball

Using sensory integration therapy tools can help patients and families live more successful and satisfying lives. 

For news not listed on this page view the Jefferson News Archive